The number of people with susceptibility test result for rifampicin in China
China: The number of people with susceptibility test result for rifampicin was 237,238 in 2021. ▲ Rising
Latest (2021)
237,238
Change on year
down 4.6%
World rank
2nd
of 155 countries
All-time high
248,587
in 2020
All-time low
89,171
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in China, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in China is 237,238, measured in 2021.
Compared with earlier readings it is down 4.6% on the previous year and up 166.0% over five years.
China ranks 2nd of 155 countries on this measure, in the top 10%.
The number of people with susceptibility test result for rifampicin in China, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 89,171 | — |
| 2018 | 144,192 | +61.7% |
| 2019 | 235,901 | +63.6% |
| 2020 | 248,587 | +5.4% |
| 2021 | 237,238 | -4.6% |
China compared with similar countries
- China's 237,238 is above the median for upper middle income countries, which is 880, 269.6× the median. (46 countries reporting)
- China's 237,238 is above the median for East Asia & Pacific, which is 185, 1282.4× the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 156,421 | 89,171 | 235,901 | 3 |
| 2020s | 242,912 | 237,238 | 248,587 | 2 |
Countries ranked near China
More health data for China
- Un projection of annual infant deaths, annual growth rate -1.15 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0985 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,029 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,642 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 10 (2025)
- Population ages 00-04, female, annual growth rate -8.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0159 units per person (2025)
- Population ages 00-04, male, annual growth rate -8.73 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in China?
- The number of people with susceptibility test result for rifampicin in China was 237,238 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in China?
- The highest recorded value was 248,587 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in China?
- The lowest recorded value was 89,171 in 2017.
- How does China rank for the number of people with susceptibility test result for rifampicin?
- China ranks 2nd out of 155 countries with data for 2021.
- Where does this China data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).